NSC |
Compound |
Enrichment |
Correlation |
NSC 679261 |
Null |
0.0129421834592789 |
-0.053485859 |
NSC 719667 |
7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one |
0.0129421834592789 |
0.19238186 |
NSC 725098 |
Null |
0.0129421834592789 |
0.21527965 |
NSC 743433 |
8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one |
0.0129421834592789 |
0.31719984 |
NSC 752506 |
5-nitro-N-((pyridin-3-yl)methyl)furan-2-carboxamide |
0.012942183459279 |
0.25789901 |
NSC 268665 |
Null |
0.0133012546828912 |
0.14048683 |
NSC 5355 |
Benzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium, 5,6-dihydro-9,10-dimethoxy-, sulfate (2:1) (9CI) |
0.0133012546828912 |
0.011591929 |
NSC 59620 |
(4a,6a,9-trimethyl-6,7-dioxo-2,3,4,4b,5,6b,10,10a,11,11a,11b,12,13,13a-tetradecahydro-1H-indeno[2,1-a]phenanthren-2-yl) acetate |
0.0133012546828912 |
0.36701038 |
NSC 641390 |
Null |
0.0133012546828912 |
0.46128661 |
NSC 646924 |
Null |
0.0133012546828912 |
-0.035014716 |